- Big Bank Phobia: Not Too Big to Fail
- Expect Your Health Care in Retirement to Hit $200,000
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- Tim Cook Should Tell Congress to Kiss His Ass
- 5 Worst Home Renovation Projects
Article
Beyond the Lede: Playing the Industrial Trough (RealMoney.com $)
Goldman upgrades the early recovery plays; also, gauging Chinese growth and the swine flu effect on pork producers.
01:19PM 04/27/09
Article
BMY Preview: Staying Ahead of the Patent Losses (RealMoney.com $)
Expect a lively Q&A as management finesses the robust pipeline prospects in the face of coming generic exposure.
12:12PM 04/27/09
Article
Ford: Solid Cost Control, but Sales Must Rebound Soon (RealMoney.com $)
The stock's impressive rebound makes investors look well into the next decade to justify further gains.
11:38AM 04/24/09
Article
Friday's call should shed light on the company's cost structure and staying power.
10:00AM 04/23/09
Article
Two for the Coming IT Upturn (RealMoney.com $)
Underappreciated Micron and NetScout should see major gains from a tech rebound.
08:31AM 04/23/09
Article
Ford: The Last Brutal Quarter (RealMoney.com $)
Friday's call should shed light on the company's cost structure and staying power.
11:59AM 04/22/09
Article
Solid Numbers From Steady Shooter Gilead (RealMoney.com $)
If it develop a robust franchise in cardiac treatments, Gilead can maintain an above-growth multiple.
05:38PM 04/21/09
Article
Solar Preview: Tough First Half, but Better Days Ahead (RealMoney.com $)
As Congress debates clean energy, key beneficiaries will likely further dampen near-term expectations.
03:44PM 04/21/09
Article
GILD Preview: Doing OK -- for Now (RealMoney.com $)
All signs point to quarterly strength, though long-term growth rates are cooling.
04:32PM 04/20/09
Article
Beyond the Lede: Jumping the Gun on a Turnaround (RealMoney.com $)
Investors are looking out several years to justify recent gains. Also, the M&A party is in full bloom.
02:31PM 04/20/09